A Randomized, Open-label, Multiple-dose, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects.

Trial Profile

A Randomized, Open-label, Multiple-dose, Crossover Study to Evaluate a Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2014

At a glance

  • Drugs Itopride (Primary) ; Revaprazan (Primary)
  • Indications Duodenal ulcer; Gastric ulcer; Gastritis; Irritable bowel syndrome
  • Focus Pharmacokinetics
  • Sponsors Yuhan
  • Most Recent Events

    • 31 Jul 2012 Bioequivalence of combination therapy and monotherapy with regards to the primary endpoints 'Area-under-the-drug-concentration-time-curve' and 'Peak-drug-concentration' has been met according to results published in Clinical Therapeutics.
    • 31 Jul 2012 Results published in Clinical Therapeutics.
    • 22 Apr 2012 Results presented at the 113th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top